BharatH.BaraiMD

Oncology • Merrillville, IN

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Clin Asst Professor of Medicine, Indiana University Medical School

Join to view full profile

Dr. Barai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Barai's full profile

Already have an account?

Office
200 E 89th Ave
Suite 2a
Merrillville, IN 46410
Phone+1 219-736-2800

Fax+1 219-736-6680
Is this information wrong?

Education & Training

Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1980
Northwestern Memorial Hospital1977 - 1979
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1975 - 1977
Baroda Medical CollegeClass of 1971

Certifications & Licensure

IN State Medical License 1980 - 2025
IL State Medical License 1976 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry Start of enrollment: 2015 Nov 01
Completed
Join now to see all

Press Mentions

Hyderabad-Based Biological E Partners with J&J for Vaccine ManufacturingMay 19th, 2021
Hydroxychloroquine Given Under Supervision, Side Effects Can Be Addressed: Indian-American DoctorMay 26th, 2020
Hollywood Celebs to Join Indian American Physicians’ Annual Meet in ChicagoFebruary 6th, 2020